Become A Featured Company

HempFusion Prepares to Go Public as a Unique Play on CBD

Ryan Allway

December 18th, 2020

App, Exclusive, News, Top News

Charlotte’s Web Holdings Inc. (TSX: CWEB) bought Abacus Health Products Inc. in a stock transaction worth about $100 million last June. With competition on the rise in the CBD industry, Abacus provided Charlotte’s Web with a portfolio of over-the-counter (OTC) topical products that combined active pharmaceutical ingredients with hemp extracts.

HempFusion Inc. (TSX: CBD.U – reserved) has taken a similar approach with its portfolio of proprietary OTC FDA Drug Listed topical products. By going through the lengthy and costly approval process, the company can make unique health claims that differentiate its products including: pain relief, eczema relief and acne relief.

Click here to receive an investor presentation and IPO alert

Unique Product Portfolio

HempFusion Co-Founder and CEO Jason Mitchell, N.D. was instrumental in building Country Life Vitamins, a leader in health and wellness supplements, as Chief Science Officer. Building upon that experience, he co-founded HempFusion and Probulin to focus on next-generation probiotic supplements and unlocking the promise of phytocannabinoids like CBD.

After several years and over $2 million in capital investment, Mitchell helped secure OTC Drug Listed status for its line of topical CBD products targeting pain relief, wound healing, anti-aging, and other categories. The company’s other products include proprietary blends designed to support healthy sleep, promote energy and reduce anxiety.

Charlotte’s Web’s acquisition of Abacus Health underscores the uniqueness of the ability to make these claims. After all, most CBD companies don’t have the time or capital required to advance products through the years-long and multi-million-dollar process of securing FDA OTC Drug Listed status for their product lines; and therefore, cannot make impactful health claims. 

The company’s OTC Drug Listed portfolio provides both a competitive barrier to entry and an important marketing advantage on store shelves. In addition to these qualities, the company has already built robust distribution channels, including Amazon.com, Whole Foods, Sprouts and the Vitamin Shoppe with plans to move into Big Box (Food & Drug Mass) and convenience stores soon.

Click here to receive an investor presentation and IPO alert

IPO on a Senior Exchange

HempFusion plans to complete its Initial Public Offering on Canada’s Toronto Stock Exchange (TSX) in December. After setting out to raise $17 million, the company immediately saw a heavily oversubscribed order book with interest from both accredited investors in the United States and non-accredited investors in Canada.

With the second largest cash position in the industry at about $18 million as of June 2020, the company’s $17 million capital raise will provide ample capital to pursue its ambitious plans to reach 150,000 retail locations over time. Its focus on ecommerce could further help it dominate a space that has seen record levels of consumer interest.

The Brightfield Group projects that the U.S. CBD market will reach $16.8 billion by 2025. The company believes that the growth will reward companies that react quickly to the market and ultimately unlock significant value.

Looking Ahead

HempFusion is well positioned to capitalize on growing demand for CBD products. With OTC Drug Listed status, it has a unique marketing advantage compared to other products that have become ubiquitous on store shelves. The funding from its IPO should help expand its distribution and revenue over the coming quarters. 

For more information, visit the company’s website or download their investor presentation.

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading